Memo Therapeutics
Tracked across 1 events · 16 articles · First seen Jul 01, 2026 · Last active Jul 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Memo Therapeutics was acquired by Ipsen, providing an exit for its investors and advancing its lead asset, potravitug, under a larger pharmaceutical company.
Jul 01, 2026 · 16 articles
ERGEN INTELLIGENCE
Track Memo Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard